Performance of a multiplex polymerase chain reaction panel for identifying bacterial pathogens causing pneumonia in critically ill patients with COVID-19

被引:35
|
作者
Camelena, Francois [1 ,2 ]
Moy, Anne-Clotilde [3 ,4 ]
Dudoignon, Emmanuel [3 ,4 ,5 ]
Poncin, Thibaut [1 ,2 ]
Deniau, Benjamin [3 ,4 ,5 ]
Guillemet, Lucie [3 ,4 ]
Le Goff, Jerome [1 ]
Budoo, Melissa [1 ]
Benyamina, Mourad [3 ,4 ]
Chaussard, Maite [3 ,4 ]
Coutrot, Maxime [3 ,4 ]
Lafaurie, Matthieu [6 ]
Plaud, Benoit [3 ,4 ,5 ]
Mebazaa, Alexandre [3 ,4 ,5 ]
Depret, Francois [3 ,4 ,5 ]
Bercot, Beatrice [1 ,2 ]
机构
[1] St Louis Lariboisiere Hosp Grp, AP HP, Dept Microbiol, Paris, France
[2] Univ Paris, INSERM 1137, IAME, Paris, France
[3] St Louis Lariboisiere Hosp Grp, AP HP, Dept Anesthesiol & Crit Care, Paris, France
[4] St Louis Lariboisiere Hosp Grp, AP HP, Burn Unit, Paris, France
[5] Univ Paris, INSERM 942, INI CRCT Network, Paris, France
[6] St Louis Lariboisiere Hosp Grp, AP HP, Dept Infect Dis, Paris, France
关键词
FilmArray Pneumonia Plus; SARS-CoV-2; Bacterial pneumonia; Rapid diagnostics; VENTILATOR-ASSOCIATED PNEUMONIA;
D O I
10.1016/j.diagmicrobio.2020.115183
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
The FilmArray (R) Pneumonia Plus (FA-PP) panel can provide rapid identifications and semiquantitative results for many pathogens. We performed a prospective single-center study in 43 critically ill patients with coronavirus disease 2019 (COVID-19) in which we performed 96 FA-PP tests and cultures of blind bronchoalveolar lavage (BBAL). FA-PP detected 1 or more pathogens in 32% (31/96 of samples), whereas culture methods detected at least 1 pathogen in 35% (34/96 of samples). The most prevalent bacteria detected were Pseudomonas aeruginosa (n = 14) and Staphylococcus aureus (n = 11) on both FA-PP and culture. The FA-PP results from BBAL in critically ill patients with COVID-19 were consistent with bacterial culture findings for bacteria present in the FA-PP panel, showing sensitivity, specificity, and positive and negative predictive value of 95%, 99%, 82%, and 100%, respectively. Median turnaround time for FA-PP was 5.5 h, which was significantly shorter than for standard culture (26 h) and antimicrobial susceptibility testing results (57 h). (C) 2020 Elsevier Inc. All rights reserved.
引用
收藏
页数:4
相关论文
共 45 条
  • [41] Diagnostic concordance between BioFire® FilmArray® Pneumonia Panel and culture in patients with COVID-19 pneumonia admitted to intensive care units: the experience of the third wave in eight hospitals in Colombia
    Francisco José Molina
    Luz Elena Botero
    Juan Pablo Isaza
    Luz Elena Cano
    Lucelly López
    Leidy Tamayo
    Antoni Torres
    Critical Care, 26
  • [42] High-Dose Steroids for Nonresolving Acute Respiratory Distress Syndrome in Critically Ill COVID-19 Patients Treated With Dexamethasone: A Multicenter Cohort Study
    Lopinto, Julien
    Arrestier, Romain
    Peiffer, Bastien
    Gaillet, Antoine
    Voiriot, Guillaume
    Urbina, Tomas
    Luyt, Charles-Edouard
    Bellaiche, Raphael
    Pham, Tai
    Ait-Hamou, Zakaria
    Roux, Damien
    Clere-Jehl, Raphael
    Azoulay, Elie
    Gaudry, Stephane
    Mayaux, Julien
    Mekontso Dessap, Armand
    Canoui-Poitrine, Florence
    de Prost, Nicolas
    CRITICAL CARE MEDICINE, 2023, 51 (10) : 1306 - 1317
  • [43] Proton pump inhibitors in critically ill mechanically ventilated patients with COVID-19: protocol for a substudy of the Re-EValuating the Inhibition of Stress Erosions (REVISE) Trial
    Dennis, Brittany B.
    Thabane, Lehana
    Heels-Ansdell, Diane
    Dionne, Joanna C.
    Binnie, Alexandra
    Tsang, Jennifer
    Guyatt, Gordon
    Ahmed, Aijaz
    Lauzier, Francois
    Deane, Adam
    Arabi, Yaseen
    Marshall, John
    Zytaruk, Nicole
    Saunders, Lois
    Finfer, Simon
    Myburgh, John
    Muscedere, John
    English, Shane
    Ostermann, Marlies
    Hardie, Miranda
    Knowles, Serena
    Cook, Deborah
    TRIALS, 2023, 24 (01)
  • [44] Proton pump inhibitors in critically ill mechanically ventilated patients with COVID-19: protocol for a substudy of the Re-EValuating the Inhibition of Stress Erosions (REVISE) Trial
    Brittany B. Dennis
    Lehana Thabane
    Diane Heels-Ansdell
    Joanna C. Dionne
    Alexandra Binnie
    Jennifer Tsang
    Gordon Guyatt
    Aijaz Ahmed
    François Lauzier
    Adam Deane
    Yaseen Arabi
    John Marshall
    Nicole Zytaruk
    Lois Saunders
    Simon Finfer
    John Myburgh
    John Muscedere
    Shane English
    Marlies Ostermann
    Miranda Hardie
    Serena Knowles
    Deborah Cook
    Trials, 24
  • [45] Clinical Outcomes and Prolonged SARS-CoV-2 Viral Shedding in ICU Patients with Severe COVID-19 Infection and Nosocomial Bacterial Pneumonia: A Retrospective Cohort Study
    Sun, Chuan-Yen
    Feng, Jia-Yih
    Huang, Jhong-Ru
    Shen, Hisao-Chin
    Chen, Yuh-Min
    Chen, Wei-Chih
    Yang, Kuang-Yao
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (22)